Macular Degeneration News and Research

Latest Macular Degeneration News and Research

A software-based on AI helps assess the progression of geographic atrophy

A software-based on artificial intelligence (AI), which was developed by researchers at the Eye Clinic of the University Hospital Bonn, Stanford University and University of Utah, enables the precise assessment of the progression of geographic atrophy (GA), a disease of the light sensitive retina caused by age-related macular degeneration (AMD).

13 Aug 2020

Scientists identify new treatment targets for blinding retinal disease

When the eye isn't getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists have identified new points where they may be able to calm the frenzy and instead enable recovery

10 Aug 2020

Immune system's oldest branches may underpin COVID severity

One of the immune system's oldest branches, called complement, may be influencing the severity of COVID disease, according to a new study from researchers at Columbia University Irving Medical Center.

3 Aug 2020

Dr Alan Howard empowers millions with innovative contributions to human health

Dr Alan Norman Howard, who has died peacefully at the age of 91, was a pioneer in the field of nutrition and obesity whose work achieved global commercial success.

31 Jul 2020

Scientists discover promising drug target for dry age-related macular degeneration

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration, a leading cause of vision loss in Americans 60 years of age and older.

20 Jul 2020

A new strategy to combat treatment resistance in choroidal neovascularization

An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration, the leading cause of irreversible blindness in the elderly.

16 Jul 2020

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.

15 Jul 2020

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

In experiments in rats and mice, two Johns Hopkins scientists -; an engineer and an ophthalmologist -; report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

7 Jul 2020

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

An international team of scientists, of which the University of Granada (UGR) is a member, has developed a new nanoparticle-based artificial retina prosthesis that can be injected into the eye.

7 Jul 2020

Exercise can slow or prevent macular degeneration

Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.

1 Jul 2020

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) has led to the revolutionary development of an artificial liquid retinal prosthesis to counteract the effects of diseases such as retinitis pigmentosa and age-related macular degeneration that cause the progressive degeneration of photoreceptors of the retina, resulting in blindness.

30 Jun 2020

Seniors in low-income housing live in fear of COVID infection

Davetta Brooks, 75, who has heart failure, a fractured hip and macular degeneration, is afraid. Conditions in her low-income senior building on Chicago's Near West Side — the Congressman George W. Collins Apartments — are "deplorable," she said.

26 Jun 2020

Making AI systems to diagnose more like a doctor

Artificial intelligence (AI) is an important innovation in diagnostics, because it can quickly learn to recognize abnormalities that a doctor would also label as a disease.

24 Jun 2020

Hungarian physician to receive the Körber Prize for European Science 2020

The Körber Prize for European Science 2020, which is endowed with one million euros, is being awarded to the Hungarian physician Botond Roska.

23 Jun 2020

People with sight loss are greatly affected by Covid-19 pandemic, survey shows

A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.

4 Jun 2020

Microperimetry can help determine the efficacy of novel treatments for macular diseases

Stargardt disease is an inherited eye disease. Its onset is typically in adolescence and it is among the leading causes of blindness in this age group. Symptoms range from severe loss of sharp vision to almost complete loss of sight.

2 Jun 2020

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Boehringer Ingelheim and CDR-Life today announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic atrophy (GA).

From Boehringer Ingelheim International GmbH 15 May 2020

New survey gains broader insights into the personal impact of Covid-19 on people with eye conditions

Eye research charity Fight for Sight has launched a survey to gather broader insights into the personal impact that Covid-19 is having on people with sight loss and eye conditions.

7 May 2020

Scientists identify unexpected player that causes vision loss in patients with AMD

Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.

6 May 2020

AI-based technology could help accelerate clinical trials for glaucoma

The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.

4 May 2020

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

A software-based on AI helps assess the progression of geographic atrophy

Scientists identify new treatment targets for blinding retinal disease

Immune system's oldest branches may underpin COVID severity

Dr Alan Howard empowers millions with innovative contributions to human health

Scientists discover promising drug target for dry age-related macular degeneration

A new strategy to combat treatment resistance in choroidal neovascularization

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

Exercise can slow or prevent macular degeneration

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Seniors in low-income housing live in fear of COVID infection

Making AI systems to diagnose more like a doctor

Hungarian physician to receive the Körber Prize for European Science 2020

People with sight loss are greatly affected by Covid-19 pandemic, survey shows

Microperimetry can help determine the efficacy of novel treatments for macular diseases

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

New survey gains broader insights into the personal impact of Covid-19 on people with eye conditions

Scientists identify unexpected player that causes vision loss in patients with AMD

AI-based technology could help accelerate clinical trials for glaucoma

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in